Compare IDEXX Laboratories, Inc. (IDXX) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Inovio Pharmaceuticals Inc — how do they compare? IDEXX Laboratories, Inc. trades at $563.81 (market cap $44.48B), while Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M). The key difference: IDEXX Laboratories, Inc. is far larger — about 498.3× Inovio Pharmaceuticals Inc's market cap, and IDEXX Laboratories, Inc. is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| IDXX | INO | |
|---|---|---|
Market Cap | $44.48B | $89.27M |
Sector | Health | Health |
52-Week High | $766.68 | $2.87 |
52-Week Low | $520.87 | $1.05 |
Enterprise Value | $45.38B | $60.28M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
